These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7043084)

  • 1. Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids.
    Westermark P; Shirahama T; Skinner M; Brun A; Cameron R; Cohen AS
    Lab Invest; 1982 May; 46(5):457-60. PubMed ID: 7043084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
    Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
    J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of amyloid P component in human brain: vascular staining patterns and association with Alzheimer's disease lesions.
    Perlmutter LS; Barrón E; Myers M; Saperia D; Chui HC
    J Comp Neurol; 1995 Jan; 352(1):92-105. PubMed ID: 7714241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders.
    Murphy GM; Forno LS; Higgins L; Scardina JM; Eng LF; Cordell B
    Am J Pathol; 1994 May; 144(5):1082-8. PubMed ID: 8178931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-amyloid fibrils of Alzheimer's disease: pathologically altered, basement membrane-associated microfibrils?
    Inoue S; Kisilevsky R
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):93-102. PubMed ID: 11730002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular basement membrane components and the lesions of Alzheimer's disease: light and electron microscopic analyses.
    Perlmutter LS; Myers MA; Barrón E
    Microsc Res Tech; 1994 Jun; 28(3):204-15. PubMed ID: 8068983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease.
    Pirim I; Erdogan AR; Tan U
    Int J Neurosci; 2004 Jan; 114(1):75-81. PubMed ID: 14660069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of a novel protein in calf serum that recognizes beta amyloid in the formalin-fixed section.
    Kanemaru K; Hasegawa M; Shimada H; Ihara Y
    Am J Pathol; 1990 Sep; 137(3):677-87. PubMed ID: 1698030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical study of alpha 1-antichymotrypsin in the senescent cerebral amyloid.
    Shoji M; Harigaya Y; Yamaguchi H; Okamoto K; Hirai S; Takatama M
    Prog Clin Biol Res; 1989; 317():1049-59. PubMed ID: 2690085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
    Thal DR; Ghebremedhin E; Haass C; Schultz C
    Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral amyloid angiopathy. Frequency, significance and immunohistochemistry.
    Sillus M; Saeger W; Linke RP; Müller D; Voigt C
    Zentralbl Pathol; 1993 Aug; 139(3):207-15. PubMed ID: 7692958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease.
    Hawkins PN; Rossor MN; Gallimore JR; Miller B; Moore EG; Pepys MB
    Biochem Biophys Res Commun; 1994 Jun; 201(2):722-6. PubMed ID: 7516157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease.
    Linke RP
    Clin Neuropathol; 1982; 1(4):172-82. PubMed ID: 6301727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.
    Kalaria RN; Galloway PG; Perry G
    Neuropathol Appl Neurobiol; 1991 Jun; 17(3):189-201. PubMed ID: 1891063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuropathology of Alzheimer's disease.
    Wisniewski HM; Wegiel J
    Neuroimaging Clin N Am; 1995 Feb; 5(1):45-57. PubMed ID: 7743084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease.
    Chargé SB; Esiri MM; Bethune CA; Hansen BC; Clark A
    J Pathol; 1996 Aug; 179(4):443-7. PubMed ID: 8869295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.